×
验证码:
换一张
忘记密码?
记住我
切换中国科技网通行证登录
×
切换中国科技网通行证登录
登录
中文版
|
English
中国科学院合肥物质科学研究院机构知识库
Knowledge Management System of Hefei Institute of Physical Science,CAS
登录
注册
ALL
ORCID
题名
作者
学科领域
关键词
文献类型
出处
收录类别
出版者
发表日期
存缴日期
资助项目
学科门类
学习讨论厅
图片搜索
粘贴图片网址
首页
研究单元&专题
作者
文献类型
学科分类
知识图谱
新闻&公告
在结果中检索
研究单元&专题
中科院强磁场科学中... [14]
全文传递库 [2]
中科院等离子体物理研... [1]
作者
刘青松 [12]
吴宏 [12]
王文超 [12]
王傲莉 [11]
胡晨 [11]
王薇 [10]
更多...
发表日期
2022 [4]
2021 [3]
2017 [13]
2016 [2]
2014 [1]
2013 [2]
更多...
语种
英语 [27]
出处
JOURNAL OF... [8]
CHINESE ME... [3]
ONCOTARGET [3]
ACS CHEMIC... [1]
ACTA PHARM... [1]
ANNALS OF ... [1]
更多...
资助项目
[Zhejiang ... [2]
Fund of th... [1]
National N... [1]
National N... [1]
Scientific... [1]
[Chinese G... [1]
更多...
资助机构
National ... [10]
CAS/SAFEA ... [9]
Chinese Ac... [9]
Hefei Scie... [9]
National N... [9]
National P... [9]
更多...
收录类别
SCI [20]
CSCD [5]
摘要
文献类型
期刊论文 [27]
学位论文 [2]
×
知识图谱
HFCAS OpenIR
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共29条,第1-10条
帮助
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
WOS被引频次升序
WOS被引频次降序
题名升序
题名降序
发表日期升序
发表日期降序
作者升序
作者降序
期刊影响因子升序
期刊影响因子降序
提交时间升序
提交时间降序
Gefitinib enhances the anti-tumor immune response against EGFR-mutated NSCLC by upregulating B7H5 expression and activating T cells via CD28H
期刊论文
INTERNATIONAL JOURNAL OF ONCOLOGY, 2022, 卷号: 61
作者:
Guo, Huihui
;
Zhang, Xilin
;
Xie, Shangzhi
;
Chen, Tianwei
;
Xie, Dong
;
Cai, Ying
;
Cui, Dawei
;
Wang, Liang
;
Chen, Wei
;
Wang, Xiang
收藏
  |  
浏览/下载:29/0
  |  
提交时间:2022/12/22
gefitinib
CD28H
NSCLC
EGFR mutation
The effect of EGFR-TKIs on survival in advanced non-small-cell lung cancer with EGFR mutations: A real-world study
期刊论文
CANCER MEDICINE, 2022
作者:
Yu, Xiaoqing
;
Si, Jinfei
;
Wei, Jingwen
;
Wang, Yanling
;
Sun, Yan
;
Jin, Jianan
;
Zhang, Xiaoyan
;
Ma, Tonghui
;
Song, Zhengbo
收藏
  |  
浏览/下载:40/0
  |  
提交时间:2022/12/23
EGFR-TKIs
non-small cell lung cancer (NSCLC)
real-world study
survival outcome
Impact of clinical and molecular features on efficacy and outcome of patients with non-small cell lung cancer receiving second-line osimertinib
期刊论文
BMC CANCER, 2022, 卷号: 22
作者:
Jin, Ying
;
Lin, Chen
;
Shi, Xun
;
He, Qiong
;
Yan, Junrong
;
Yu, Xinmin
;
Chen, Ming
收藏
  |  
浏览/下载:30/0
  |  
提交时间:2022/12/23
Clinical and molecular features
Efficacy and outcome
EGFR T790M mutation
Non-small-cell lung cancer
Osimertinib
Efficacy and safety of anlotinib with and without EGFR-TKIs or immunotherapy in the treatment of elder patients with non-small-cell lung cancer: a retrospective study
期刊论文
BMC PULMONARY MEDICINE, 2022, 卷号: 22
作者:
Wang, Wenxian
;
Shao, Lan
;
Xu, Yibing
;
Song, Zhengbo
;
Lou, Guangyuan
;
Zhang, Yiping
;
Chen, Ming
收藏
  |  
浏览/下载:24/0
  |  
提交时间:2022/12/23
Non-small cell lung cancer
Prognosis
Angiogenesis
Tyrosine kinase inhibitors
Clinical outcomes of lung adenocarcinoma patients harboring uncommon epidermal growth factor receptor (EGFR) mutations treated with EGFR-tyrosine kinase inhibitors (TKIs)
期刊论文
ANNALS OF PALLIATIVE MEDICINE, 2021
作者:
Si, Jinfei
;
Gu, Xiaodong
;
Wang, Wenxian
;
Ying, Shenpeng
;
Song, Zhengbo
收藏
  |  
浏览/下载:89/0
  |  
提交时间:2022/02/14
Epidermal growth factor receptor (EGFR)
uncommon mutation
compound mutation
double uncommon mutation
lung adenocarcinoma (lung AC)
The correlation between the abundance of EGFR T790M mutation and osimertinib response in advanced non-small cell lung cancer
期刊论文
TRANSLATIONAL CANCER RESEARCH, 2021, 卷号: 10
作者:
Pan, Guoqiang
;
Chen, Kaiyan
;
Yu, Xiaoqing
;
Sheng, Jiamin
;
Fan, Yun
收藏
  |  
浏览/下载:42/0
  |  
提交时间:2021/11/01
Non-small cell lung cancer (NSCLC)
T790M abundance
droplet digital PCR (ddPCR)
next generation sequencing (NGS)
osimertinib
The genomic landscape of young and old lung cancer patients highlights age-dependent mutation frequencies and clinical actionability in young patients
期刊论文
INTERNATIONAL JOURNAL OF CANCER, 2021
作者:
Cai, Lei
;
Chen, Yong
;
Tong, Xiaoling
;
Wu, Xue
;
Bao, Hua
;
Shao, Yang
;
Luo, Zhuang
;
Wang, Xuming
;
Cao, Yang
收藏
  |  
浏览/下载:71/0
  |  
提交时间:2021/06/15
EGFR
ERBB2
gene fusions
tyrosine kinase inhibitors
young lung cancer patients
Discovery of N-(5-((5-chloro-4-((2-(isopropylsulfonyl)phenyl)amino)pyrimidin-2-yl)amino)-4-methoxy-2-(4-methyl-1,4-diazepan-1-yl)phenyl)acrylamide (CHMFL-ALK/EGFR-050) as a potent ALK/EGFR dual kinase inhibitor capable of overcoming a variety of ALK/EGFR associated drug resistant mutants in NSCLC
期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 卷号: 139, 期号: 无, 页码: 674-697
作者:
Chen, Yongfei
;
Wu, Jiaxin
;
Wang, Aoli
;
Qi, Ziping
;
Jiang, Taoshan
;
Chen, Cheng
;
Zou, Fengming
;
Hu, Chen
;
Wang, Wei
;
Wu, Hong
;
Hu, Zhenquan
;
Wang, Wenchao
;
Wang, Beilei
;
Wang, Li
;
Ren, Tao
;
Zhang, Shanchun
;
Liu, Qingsong
;
Liu, Jing
浏览
  |  
Adobe PDF(12656Kb)
  |  
收藏
  |  
浏览/下载:21274/11466
  |  
提交时间:2018/08/17
Egfr
Alk
Dual Kinase Inhibitor
Non-small Cell Lung Cancer
Discovery of (R)-1-(3-(4-Amino-3-(3-chloro-4-(pyridin-2-ylmethoxy)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one (CHMFL-EGFR-202) as a Novel Irreversible EGFR Mutant Kinase Inhibitor with a Distinct Binding Mode
期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 卷号: 60, 期号: 7, 页码: 2944-2962
作者:
Wang, Aoli
;
Li, Xixiang
;
Wu, Hong
;
Zou, Fengming
;
Yan, Xiao-E
;
Chen, Cheng
;
Hu, Chen
;
Yu, Kailin
;
Wang, Wenchao
;
Zhao, Peng
;
Wu, Jiaxin
;
Qi, Ziping
;
Wang, Wei
;
Wang, Beilei
;
Wang, Li
;
Ren, Tao
;
Zhang, Shanchun
;
Yun, Cai-Hong
;
Liu, Jing
;
Liu, Qingsong
收藏
  |  
浏览/下载:27/0
  |  
提交时间:2018/07/26
Discovery of (R)-1-(3-(4-Amino-3-(3-chloro-4-(pyridin-2-ylmethoxy)phenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one (CHMFL-EGFR-202) as a Novel Irreversible EGFR Mutant Kinase Inhibitor with a Distinct Binding Mode
期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 卷号: 60, 期号: 7, 页码: 2944-2962
作者:
Wang, Aoli
;
Li, Xixiang
;
Wu, Hong
;
Zou, Fengming
;
Yan, Xiao-E
;
Chen, Cheng
;
Hu, Chen
;
Yu, Kailin
;
Wang, Wenchao
;
Zhao, Peng
;
Wu, Jiaxin
;
Qi, Ziping
;
Wang, Wei
;
Wang, Beilei
;
Wang, Li
;
Ren, Tao
;
Zhang, Shanchun
;
Yun, Cai-Hong
;
Liu, Jing
;
Liu, Qingsong
收藏
  |  
浏览/下载:47/0
  |  
提交时间:2018/07/26